Share

Health care researcher: Four questions to ask about Pfizer and BioNTech vaccine

Tara Raveendran, head of life sciences research at Shore Capital, analyzes the read-outs from the late-stage Pfizer and BioNTech Covid-19 vaccine trial.
04:11
Tue, Nov 10 20203:45 AM EST